The effect of palonosetron on rocuronium-induced withdrawal movement
O efeito de palonosetron sobre o movimento de retração induzido por rocurônio
Ki-Bum Park; Younghoon Jeon; Junggu Yi; Ji-hyun Kim; Seung-Yeon Chung; Kyung-Hwa Kwak
Abstract
Keywords
Resumo
Palavras-chave
References
Ahmad N, Choy CY, Aris EA. Preventing the withdrawal response associated with rocuronium injection: a comparison of fentanyl with lidocaine. Anesth Analg. 2005;100:987-90.
Memis D, Turan A, Karamanlioglu B. The prevention of pain from injection of rocuronium by ondansetron, lidocaine, tramadol, and fentanyl. Anesth Analg. 2002;94:1517-20.
Lui J, Huang S, Yang C. Rocuronium-induced generalized spontaneous movements cause pulmonary aspiration. Chang Gung Med J. 2002;25:617-20.
Sufka KJ, Schomburg FM, Giordano J. Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol Biochem Behav. 1992;41:53-6.
Tambeli CH, Oliveira MC, Clemente JT. A novel mechanism involved in 5-hydroxytryptamine-induced nociception: the indirect activation of primary afferents. Neuroscience. 2006;141:1517-24.
Bravo-Hernández M, Cervantes-Durán C, Pineda-Farias JB. Role of peripheral and spinal 5-HT3 receptors in development and maintenance of formalin-induced long-term secondary allodynia and hyperalgesia. Pharmacol Biochem Behav. 2012;101:246-57.
Ye JH, Mui WC, Ren J, Hunt TE. Ondansetron exhibits the properties of a local anesthetic. Anesth Analg. 1997;85:1116-21.
Kim SH, Hong JY, Kim WO. Palonosetron has superior prophylactic antiemetic efficacy compared with ondansetron or ramosetron in high-risk patients undergoing laparoscopic surgery: a prospective, randomized, double-blinded study. Korean J Anesthesiol. 2013;64:517-23.
Stoltz R, Cyong JC, Shah A. Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and japanese healthy subjects. J Clin Pharmacol. 2004;44:520-31.
Park S, Cho E. A randomized, double-blind trial of palonosetron compared with ondansetron in preventing postoperative nausea and vomiting after gynaecological laparoscopic surgery. J Int Med Res. 2011;39:399-407.
Ertugrul F. A comparison of the efficacies of different pre-treatment drugs in resolving the injection pain of rocuronium. J Int Med Res. 2006;34:665-70.
Shevchenko Y, Jocson JC, McRae VA. The use of lidocaine for preventing the withdrawal associated with the injection of rocuronium in children and adolescents. Anesth Analg. 1999;88:746-8.
Klement W, Arndt J. Pain on IV injection of some anaesthetic agents is evoked by the unphysiological osmolality or pH of their formulations. Br J Anaesth. 1991;66:189-95.
Lockey D, Coleman P. Pain during injection of rocuronium bromide. Anaesthesia. 1995;50:474.
Tuncali B, Karci A, Tuncali BE. Dilution of rocuronium to 0.5 mg/mL with 0.9% NaCl eliminates the pain during intravenous injection in awake patients. Anesth Analg. 2004;99:740-3.
Borgeat A, Kwiatkowski D. Spontaneous movements associated with rocuronium: is pain on injection the cause?. Br J Anaesth. 1997;79:382-3.
Scott R, Saunders D, Norman J. Propofol: clinical strategies for preventing the pain of injection. Anaesthesia. 1988;43:492-4.
Cheong K, Wong W. Pain on injection of rocuronium: influence of two doses of lidocaine pretreatment. Br J Anaesth. 2000;84:106-7.
Blunk J, Seifert F, Schmelz M. Injection pain of rocuronium and vecuronium is evoked by direct activation of nociceptive nerve endings. Eur J Anaesthesiol (EJA). 2003;20:245-53.
Akkaya T, Toygar P, Bedirli N. Effects of pretreatment with lidocaine or ketamine on injection pain and withdrawal movements of rocuronium. Turk J Med Sci. 2008;38:577-82.
Kim JY, Kwak HJ, Kim JY. Prevention of rocuronium-induced withdrawal movement in children: a comparison of remifentanil with alfentanil. Pediatric Anesthesia. 2008;18:245-50.
Jeon Y, Baek SU, Park SS. Effect of pretreatment with acetaminophen on withdrawal movements associated with injection of rocuronium: a prospective, randomized, double-blind, placebo controlled study. Korean J Anesthesiol. 2010;59:13-6.
Gregory RE, Ettinger DS. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy. Drugs. 1998;55:173-89.
Zeitz KP, Guy N, Malmberg AB. The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci. 2002;22:1010-9.
Ernberg M, Lundeberg T, Kopp S. Pain and allodynia/hyperalgesia induced by intramuscular injection of serotonin in patients with fibromyalgia and healthy individuals. Pain. 2000;85:31-9.
Reddy MS, Chen FG, Ng HP. Effect of ondansetron pretreatment on pain after rocuronium and propofol injection: a randomised, double-blind controlled comparison with lidocaine. Anaesthesia. 2001;56:902-5.
Cho K, Lee SH, Lee W. Effect of pretreatment with palonosetron on withdrawal movement associated with rocuronium injection. Korean J Anesthesiol. 2014;66:23-7.
Muchatuta NA, Paech MJ. Management of postoperative nausea and vomiting: focus on palonosetron. Ther Clin Risk Manage. 2009;5:21.
Kovac AL, Eberhart L, Kotarski J. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period. Anesth Analg. 2008;107:439-44.